Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Labetolol | Labetolol EP Impurity A | VL4600001 | View CAS 1391051-99-2 |
Labetolol | Labetolol EP Impurity A (HCl) | VL4600002 | View CAS 2726492-68-6 |
Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Labetolol | Labetolol EP Impurity A | VL4600001 | View CAS 1391051-99-2 |
Labetolol | Labetolol EP Impurity A (HCl) | VL4600002 | View CAS 2726492-68-6 |
Catalogue No. | VL4600001 |
CAS No. | 1391051-99-2 |
Molecular Formula | C₁₉H₂₃NO₄ |
Molecular Weight | 329.39 |
Parent drug | Labetolol |
IUPAC Name | 2-Hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzoic Acid |
Synonyms | N/A |
References | Sci-Hub, Labetalol Hepatotoxicity, 10.7326/0003-4819-113-3-210. (2021). Retrieved December 11, 2021, from Hkvisa.net website: https://sci-hub.hkvisa.net/10.7326/0003-4819-113-3-210 |
Status | In-stock |
ListName | Labetolol EP Impurity A |
Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields